Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Glutamine in Preventing Vaso-occlusive Crisis Among Sickle Cell Disease Patients: Randomized Controlled Study

NCT05371184 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05371184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05371184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Glutamine in Preventing Vaso-occlusive Crisis Among Sickle Cell Disease Patients: Randomized Controlled Study
Lead sponsor
Ain Shams University
Phase
Phase 4
Overall status
Completed
Start date
January 4, 2022
Completion date
January 7, 2024
Enrollment
60 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease